Companies Could Get £20m Under Expanded UK Payment Model For Incentivizing Antibiotic Development

The National Health Service is seeking feedback on its plans to expand its pioneering subscription-style drug contracts to develop lifesaving antibiotics and tackle the problem of antimicrobial resistance.